Market OverviewThe Global Carrier Screening Market is a genetic testing process that determines whether an individual carries ...

GAITHERSBURG, Md. - GeneDx (NASDAQ: WGS), a genomic insights company valued at $1.64 billion, has launched its services on Aura, Epic's specialty diagnostics suite, to facilitate advanced genetic ...

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...

Personalis shows promise in cancer detection but is years away from profitability. Read why PSNL stock is rated a hold with ...

Initial test results were generated 10–20 days afterwards and ... relationships that could be construed as a potential conflict of interest. WES, whole exome sequencing; CNV-seq, copy number variants ...

The US company said that results from the Alpha-CORRECT trial saw its colon cancer diagnostic Oncodetect achieving a sensitivity rate of 91%.

Rates of genetic testing for autism and intellectual and development disorders were associated with race, gender, and insurance company.

Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research, and Exact Sciences, a leading provider of cancer screening and diagnostic tests, today ...

Introduction: For decades, conventional karyotyping analysis has been the gold standard for detecting chromosomal abnormalities during prenatal diagnosis. With the development of molecular cytogenetic ...

However, a study for coding variants is primarily relied on gene sequencing that is typically expensive especially to systematically scale whole genome in numbers of samples. Until recently, exome ...